Potent Medical strengthens its international presence through a strategic partnership with Dornier MedTech, designating Dornier as its exclusive distributor in the agreed territories across Europe, the Americas, and Asia-Pacific, advancing the global adoption of Potent’s cutting-edge Holmium:YAG laser and Thulium Fiber Laser (TFL) solutions.

Guangzhou, China, March 11, 2026 — Potent Medical, a leading manufacturer of medical laser systems and urological diagnostic equipment, is pleased to announce a strategic commercial partnership with Dornier MedTech.

Potent Medical, founded in 2004, is among the earliest Chinese manufacturers of surgical laser systems and the first in China to obtain CE and FDA certifications. With its systems installed in more than 95 countries, Potent continues to expand its global footprint and advance urology care worldwide.

Potent specializes in the development and manufacture of Holmium Laser systems, Thulium Fiber Laser systems, Electrohydraulic Lithotripsy devices, and Urodynamic Systems. Leveraging a team of experienced specialists and urologists with over 20 years of clinical expertise, Potent offers a comprehensive laser portfolio, featuring low- and high-power Holmium:YAG lasers and the advanced Thulium Fiber Laser (TFL). These solutions deliver precise tissue enucleation, efficient hemostasis, and enhanced procedural safety, and are widely adopted in clinical surgeries worldwide.

Through this collaboration, Potent Medical extends the international availability of its comprehensive laser portfolio, further advancing its international growth and highlighting its presence in strategic markets.

“We are proud to work with Dornier MedTech to bring these laser technologies globally. This partnership, founded on mutual trust and shared values, reflects our joint commitment to long-term collaboration and advancing laser technology solutions,” said Mr. Thomas Yip, Senior Vice President of Potent Medical.

“Our TFL and Holmium:YAG lasers are designed to deliver outstanding precision and efficiency in stone management and BPH treatment. Through this collaboration with Dornier MedTech, we aim to enhance patient outcomes by leveraging our combined expertise and high-performance solutions,” said Mr. Wang Kecheng, Chairman of Potent Medical. “We remain committed to innovation and research, ensuring high product quality and clinical reliability, while driving the advancement of urology medical technology.”

In a globalized era of both opportunities and challenges, Potent strives to promote the adoption of advanced minimally invasive treatment technologies in urology, improve patient outcomes worldwide.

“This move reinforces Dornier’s position as the only urology-focused company offering physicians unmatched flexibility through a robust portfolio. By integrating these technologies, it highlights Dornier’s commitment to delivering comprehensive, future-ready solutions for endourology,” said Yau Chung Wong, Global CEO of Dornier MedTech. “With this cooperation, we are solidifying our leadership in the urological care space.”

“By expanding access to our laser portfolio, we empower physicians with the flexibility to choose the right technology, for the right procedure, at the right time,” Wong continued.